Clinical Trial Update: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer [NA]

View source ↗

Summary

Clinical trial update on stereotactic ablative radiotherapy for oligometastatic cancer with 1-3 metastases; the trial status is Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Metastatic Tumors | NA | Status: ACTIVE_NOT_RECRUITING